[英语新闻]Sales from albumin up, HB immunoglobulin down?

StephenW

http://www.prnewswire.com/news-releases/china-biologic-products-reports-first-quarter-2011-results-121527019.html
TAI'AN, China, May 9, 2011 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ:   CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China (&quotRC"), today reported record sales and net income for the three months ended March 31, 2011.
Sales from human albumin products rose approximately 55.1% quarter-over-quarter to approximately $19.7 million, accounting for approximately 57.2% of the total sales in the first quarter of 2011, as compared to the 46.9% for the same period in 2010. Sales volume of human albumin products increased by approximately 63.2% in the first quarter of 2011 as compared to the same period in 2010, while average selling price ("ASP") of human albumin decreased by 4.9%. The price decrease in human albumin is due to the increasing volume of imported human albumin products during 2010.

Sales from human hepatitis B immunoglobulin declined approximately 33.5% to approximately $2.2 million, contributing approximately 6.4% of the total sales in the first quarter of 2011 as compared to approximately 12.3% in the same period of 2010. Although the ASP for sales of human hepatitis B immunoglobulin increased by 25.2% in the first quarter of 2011, its sales volume decreased by approximately 46.9%.

泰安，中国，2011年5月9日/美通社亚洲通/ -中国生物制品公司（NASDAQ：CBPO）（“中国生物“或”公司“），一个领先的等离子的生物制药在人民共和国的中国（“中华人民共和国“）公司，今天公布的销售记录，截至2011年3月31日三个月的净所得。
从人血白蛋白产品的销售额增长约约57.2％，55.1％，总销售额环比季度大约为1970万美元，占2011年第一季度相比，对在2010年同期46.9％。人血白蛋白销售产品的数量增加约63.2％，而2011年第一季度相比，2010年同期，而平均销售价格（“ASP的“）的人血白蛋白下降了4.9％。在人血白蛋白价格下降是由于进口人血白蛋白产品在2010年增加量。

从人乙型肝炎免疫球蛋白销售额下降约33.5％至约220万美元，占在2011年第一季度约6.4％，而总销售额约12.3％，2010年同期。虽然对人类B型肝炎25.2％，增加了免疫球蛋白的2011年第一季度销售的ASP，其销量下降了约46.9％。




(6.合.彩).足球.篮球...各类投注开户下注

第一投注.现金网:招代理年薪10万以上:6668.cc